SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-004225
Filing Date
2018-01-18
Accepted
2018-01-18 16:01:17
Documents
1
Period of Report
2018-01-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 25770
  Complete submission text file 0001209191-18-004225.txt   27193
Mailing Address C/O SOMAXON PHARMACEUTICALS, INC. 3721 VALLEY CENTRE DRIVE, SUITE 500 SAN DIEGO CA 92130
Business Address
LITALIEN JAMES J (Reporting) CIK: 0001182613 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37693 | Film No.: 18534009

Mailing Address 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015
Business Address 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015 972-725-7797
AveXis, Inc. (Issuer) CIK: 0001652923 (see all company filings)

IRS No.: 901038273 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)